Here’s What Lifted AstraZeneca PLC (AZN) in Q4

3 days ago 4

Soumya Eswaran

Thu, February 12, 2026 astatine 8:13 AM CST 3 min read

Carillon Tower Advisers, an concern absorption company, released its fourth-quarter 2025 capitalist missive “Carillon Eagle Growth & Income Fund”. A transcript of the missive tin beryllium downloaded here. 2025 marked a affirmative play for the equity market. The S&P 500 Index returned 2.7% successful Q4 and finished the twelvemonth up 17.9%. The twelvemonth started with imaginable disruptions and heightened volatility, portion it ended with optimism driven by beardown AI investment, clarity successful policies, and U.S. Federal Reserve (Fed) involvement complaint cuts. The market’s show was importantly affected by the connection services and exertion sectors. From a return‑driver standpoint, the marketplace enlargement successful the twelvemonth was driven by net growth. The steadfast observes favorable conditions arsenic 2026 approaches, and believes it tin execute different twelvemonth of beardown equity returns. The Fund holds nett assets of $493.06 cardinal crossed 48 holdings. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Carillon Eagle Growth & Income Fund highlighted AstraZeneca PLC (NASDAQ:AZN) arsenic a notable contributor. AstraZeneca PLC (NASDAQ:AZN) is simply a starring biopharmaceutical institution that discovers, develops, and manufactures medicine medicines. On February 11, 2026, AstraZeneca PLC (NASDAQ:AZN) banal closed astatine $204.76 per share. One-month instrumentality of AstraZeneca PLC (NASDAQ:AZN) was 8.43%, and its shares gained 37.48% of their worth implicit the past 52 weeks. AstraZeneca PLC (NASDAQ:AZN) has a marketplace capitalization of $317.436 billion.

Carillon Eagle Growth & Income Fund stated the pursuing regarding AstraZeneca PLC (NASDAQ:AZN) successful its 4th fourth 2025 capitalist letter:

"AstraZeneca PLC (NASDAQ:AZN) reported third‑quarter fiscal results that surpassed expert expectations and reaffirmed its outlook for operating borderline improvements successful 2026. The institution besides announced a constructive cause pricing statement with the Trump administration, and presented awesome objective proceedings results for a caller cause to dainty hypertension, which the institution expects to person connected the marketplace by mid‑2026."

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built connected Innovation

AstraZeneca PLC (NASDAQ:AZN) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 54 hedge money portfolios held AstraZeneca PLC (NASDAQ:AZN) astatine the extremity of the 3rd quarter, up from 48 successful the erstwhile quarter. While we admit the imaginable of AstraZeneca PLC (NASDAQ:AZN) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.